Procalcitonin and mid-regional pro-adrenomedullin test combination in sepsis diagnosis

Clinical Chemistry and Laboratory Medicine

Volumn 51, Issue 5, 2013, Pages 1059-1067

  Angeletti, Silvia ^a   Battistoni, Fabrizio ^b   Fioravanti, Marta ^b   Bernardini, Sergio ^c   Dicuonzo, Giordano ^b  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b Laboratory of Clinical Microbiology   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Mid regional pro adrenomedullin; Procalcitonin; Sepsis

Indexed keywords

ADRENOMEDULLIN; PROCALCITONIN;

ADULT; AGED; ARTICLE; BACTERIUM CULTURE; CLINICAL EVALUATION; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; GEOMETRY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEPSIS; YEAST;

ADRENOMEDULLIN; BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; CALCITONIN; HUMANS; PROTEIN PRECURSORS; SEPSIS;

EID: 84882268782     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2012-0595     Document Type: Article

References (46)

1. American College of Chest Physicians/Society of Critical Care Medicine. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-74.
2. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 2003;31:1250-6.
3. Lever A, Mackenzie I. Sepsis: definition, epidemiology, and diagnosis. Br Med J 2007;335:879-83.
4. Paul M, Shani V, Muchtar E, Kariv G, Robenshto E, Leibovici L. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother 2010;54:4851-63.
5. Stearns-Kurosawa DJ, Osuchowski MF, Valentine C, Kurosawa S, Remick DG. The pathogenesis of sepsis. Annu Rev Pathol 2011;6:19-48.
6. Heffner AC, Horton JM, Marchick MR, Jones AE. Etiology of illness in patients with severe sepsis admitted to the hospital from the emergency department. Clin Infect Dis 2010;50: 814-20.
7. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, et al. Circulating mitochondrial DAMP cause inflammatory response to injury. Nature 2010;464:104-7.
8. Castellheim A, Brekke OL, Espevik T, Harboe M, Mollness TE. Innate immune responses to danger signals in systemic inflammatory response syndrome and sepsis. Scand J Immunol 2009;69:479-91.
9. Lopez-Collazo E, Gomez-Pina V, Arnalich F. Understanding immune dysfunctions in sepsis patients. Crit Care 2010;14:435.
10. Anas AA, Wiersinga WJ, de Vos AF, van der Poll T. Recent insights into the pathogenesis of bacterial sepsis. Neth J Med 2010;68:147-52.
11. van der Poll T, Meijers JC. Systemic inflammatory response syndrome and compensatory anti-inflammatory response syndrome in sepsis. J Innate Immun 2010;2:379-80.
12. Sheldon J, Riches P, Gooding R, Soni N, Hobbs JR. C-reactive protein and its cytokine mediators in intensive-care patients. Clin Chem 1993;39:147-50.
13. Carrigan SD, Scott G, Tabrizian M. Towards resolving the challenges of sepsis diagnosis. Clin Chem 2004;50:1301-14.
14. Kofoed K, Andersen O, Kronborg G, Tvede M, Petersen J, Eugen-Olsen J, et al. Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: A prospective study. Crit Care 2007;11:R38.
15. de Kruif MD, Limper M, Gerritsen H, Spek CA, Brandjes DP, ten Cate H, et al. Additional value of procalcitonin for diagnosis of infection in patients with fever at the emergency department. Crit Care Med 2010;38:457-63.
16. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: A systematic review and meta-analysis. Clin Infect Dis 2004;39:206-17.
17. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohoun C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993;341:515-8.
18. Gaini S, Koldkjaer OG, Moller HJ, Pedersen C, Pedersen SS. A comparison of high-mobility group-box 1 protein, lipopolysaccharide-binding protein and procalcitonin in severe community-acquired infections and bacteraemia: A prospective study. Crit Care 2007;11:R76.
19. Limper M, de Kruif MD, Duits AJ, Brandjes DP, van Gorp EC. The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from non-infectious fever. J Infect 2010;60:409-16.
20. Gilbert DN. Use of plasma procalcitonin levels as an adjunct to clinical microbiology. J Clin Microbiol 2010;48:2325-9.
21. Becker KL, Snider R, Nylen ES. Procalcitonin in sepsis and systemic inflammation: A harmful biomarker and a therapeutic target. Br J Pharmacol 2010;159:253-64.
22. Becker KL. Immunoneutralization of procalcitonin or its component peptides: A promising treatment of sepsis. Clin Sci 2010;119:515-7.
23. Christ-Crain M, Morgenthaler NG, Struck J, Harbarth S, Bergmann A, Müller B. Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study. Crit Care 2005;9:R816-24.
24. Zudaire E, Portal-Nunez S, Cuttitta F. The central role of adrenomedullin in host defense. J Leukoc Biol 2006;80:237-44.
25. Hynson JP, Kapas S, Smith DM. Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev 2000;21:138-67.
26. Petti CA, Weinstein MP, Carroll KC. Systems for detection and identification of bacteria and yeast. In: Versalovic J, Carroll KC, Funke G, Joregnsen JH, landry ML, Warnock DW, editors. Manual of clinical microbiology. 10th ed. Washington: ASM Press, 2011.
27. Caruhel P, Mazier C, Kunde J, Morgenthaler NG, Darbouret B. Homogeneous time-resolved fluoroimmuno assay for the measurement of mid-regional proadrenomedullin in plasma on the fully automated system B.R.A.H.M.S KRYPTOR. Clin Biochem 2009;42:725-8.
28. Florkowski CM. Sensitivity, specificity, receiver-operating characteristic (ROC) curves and likelihood ratios: communicating the performance of diagnostic tests. Clin Biochem Rev 2008;29:S83-7.
29. Brenner H, Gefeller O. Variation of sensitivity, specificity, likelihood ratios and predictive values with disease prevalence. Stat Med 1997;16:981-91.
30. Bender R, Ange S, Freitag G, Rampisch HJ. Letters to the editors. Statist Med 1998;17:945-50.
31. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: A systematic review and meta-analysis. Crit Care Med 2006;34:1996-2003.
32. Tang BM, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007;7:210-7.
33. Jones AE, Fiechtl JF, Brown MD, Ballew JJ, Kline JA. Procalcitonin test in the diagnosis of bacteremia: A meta-analysis. Ann Emerg Med 2007;50:34-41.
34. McLean A. Procalcitonin: seeking a niche. Crit Care 2009;13:149.
35. Schuetz P, Albrich W, Mueller B. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Med 2011;9:107.
36. van Nieuwkoop C, Bonten TN, van't Wout JW, Kuijper EJ, Groeneveld GH, Becker MJ, et al. Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: A prospective observational study. Crit Care 2010;14:R206.
37. Schuetz P, Briel M, Christ-Crain M, Stolz D, Bouadma L, Wolff M, et al. Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis. Clin Infect Dis 2012;55:651-62.
38. Maisel A, Mueller C, Nowak R, Peacock WF, Landsberg JW, Ponikowski P, et al. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea. J Am Coll Cardiol 2010;55:2062-76.
39. Maisel A, Mueller C, Nowak R, Peacock WF, Landsberg JW, Ponikowski P, et al. Mid-region prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea. J Am Coll Cardiol 2011;58:1057-67.
40. Peacock WF, Nowak R, Christenson R, DiSomma S, Neath SX, Hartmann O, et al. Short-term mortality risk in emergency department acute heart failure. Acad Emerg Med 2011;18: 947-58.
41. Once MY, Dilmen U, Erdeve O, Ozdemir R, Calisici E, Yurttutan S, et al. Pro-adrenomedullin as a prognostic marker in neonatal sepsis. Pediatr Res 2012; DOI: 10.1038/pr.2012.106.
42. Travaglino F, De Berardinis B, Magrini L, Bongiovanni C, Candelli M, Silveri NG, et al. Utility of procalictonin (PCT) and mid regional pro-adrenomedullin (MR-proADM) in risk stratification of critically ill febrile patients in emergency department (ED). A comparison with APACHE II score. BMC Infect Dis 2012;12:184.
43. Pezzilli R, Barassi A, Pigna A, Morselli-Labate AM, Imbrogno A, Fabbri D, et al. Time course of proadrenomedullin in the early phase of septic shock. A comparative study with other proinflammatory proteins. Panminerva Med 2012;54:211-7.
44. Suberviola B, Castellanos-Ortega A, Llorca J, Ortiz F, Iglesias D, Prieto B. Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia. Swiss Med Wkly 2012;142:1-8.
45. Guignant C, Voirin N, Venet F, Lepape A, Monneret G. Persistent high level of circulating midregional-proadrenomedullin and increased risk of nosocomial infections after septic shock. J Trauma Acute Care Surg 2012;72:293-6.
46. Hagag AA, Elmahdy HS, Ezzat AA. Prognostic value of plasma pro-adrenomedullin and antithrombin levels in neonatal sepsis. Indian Pediatr 2011;48:471-3.